Phase 1 Keratosis Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Nucleoside Therapy in Patients With Telomere Biology Disorders
Dyskeratosis CongenitaTelomere Biology DisordersRevesz Syndrome
Suneet Agarwal36 enrolled1 locationNCT06817590
Recruiting
Phase 1Phase 2
Evaluate RLS-1496 Topical Cream for Actinic Keratosis
Actinic Keratosis (AK)
Rubedo Life Sciences, Inc.24 enrolled4 locationsNCT07340697
Recruiting
Phase 1
A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.
Actinic Keratosis (AK)
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.40 enrolled1 locationNCT07318675
Recruiting
Phase 1
The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy
Photodynamic TherapyActinic KeratosisImipramine
Wright State University24 enrolled1 locationNCT05688904